Xiangning Qiu

943 citations
24 papers · 700 indexed · h-index 9
Topics
Systemic Sclerosis and Related Diseases (8 papers)Dermatologic Treatments and Research (4 papers)RNA modifications and cancer (4 papers)

In The Last Decade

Xiangning Qiu

23 papers receiving 692 citations

Peers

Xiangning Qiu
Comparison fields: 5 of 68
  • Molecular Biology 415
  • Immunology 227
  • Cancer Research 155
  • Rheumatology 138
  • Hematology 82
Replace Chiara Angiolilli with:
Chiara Angiolilli Netherlands
Lorenzo de la Rica Spain
Simon Bornschein Belgium
Anke K. Bergmann Germany
Emmanuel J. Volanakis United States
Yingzhe Yu China
Siobhán Smith Ireland
Juo-Chin Yao United States
Soumen Chakraborty India
Gopna V. Rao United States
Xiangning Qiu relative to Chiara Angiolilli Netherlands Chiara Angiolilli's profile →
Citations per field
00.5×6.4×
Chiara Angiolilli · 1×
Citations per year

Countries citing papers authored by Xiangning Qiu

Since Specialization
Citations

This map shows the geographic impact of Xiangning Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangning Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangning Qiu more than expected).

Fields of papers citing papers by Xiangning Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangning Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangning Qiu. The network helps show where Xiangning Qiu may publish in the future.

Co-authorship network of co-authors of Xiangning Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangning Qiu. A scholar is included among the top collaborators of Xiangning Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangning Qiu. Xiangning Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 2
5 1
6 3
7 6
8 5
9 7
10 12
11 4
12 12
13 1
14 1
15 76
16
Acquired hemophilia associated with bullous pemphigoid: a case report.
8
17 9
18 59
19 120
20 79

About Xiangning Qiu

Xiangning Qiu is a scholar working on Dermatology, Pathology and Forensic Medicine and Rheumatology, having authored 24 papers that have together received 700 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (8 papers), Dermatologic Treatments and Research (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Immunology (227 citations), Cancer Research (155 citations) and Rheumatology (138 citations). Xiangning Qiu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Peter A. Jones, Yaping Li, Jun Yuan, Nan Hu, Yongqi Luo, Guiying Zhang, Qianjin Lu, Qianjin Lu, Ying Zhou and Yu‐Wen Su. Their work appears in journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026